ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements with these filters
QMS Medical Allied Services Limited is acquiring BeamOptics Scientific Private Limited. The strategic acquisition aims to expand the company's addressable market in healthcare business.
QMS Medical Allied Services executed a shareholders' agreement with investors and its subsidiary, Saarathi Healthcare, defining governance rights, veto powers, and share transfer restrictions.
QMS Medical Allied Services Limited approved a composite demerger scheme for its healthcare business and the acquisition of a 100% stake in BeamOptics Scientific Private Limited.
QMS Medical Allied Services Ltd acquired the remaining 24% stake in Saarathi Healthcare Private Limited for Rs. 14.23 Crore, making it a wholly-owned subsidiary.
QMS Medical Allied Services Limited informed the exchange regarding the dispatch of annual report links to shareholders who haven't registered their email addresses.
QMS Medical Allied Services Limited has filed its Annual Report for the financial year 2025-26. The 9th Annual General Meeting is scheduled for September 30, 2026.
QMS Medical Allied Services Limited issued the notice for its 9th Annual General Meeting scheduled for September 30, 2026.
QMS Medical Allied Services Limited has appointed Mr. Pranav Manhar Badheka as a Non-Executive Independent Director, effective September 3, 2026, for a five-year term.
QMS Medical Allied Services appointed Mr. Pranav Manhar Badheka as an Independent Director and approved the draft notice for the upcoming 9th Annual General Meeting.
QMS Medical Allied Services secured exclusive Indian marketing and distribution rights for HEINE Optotechnik's diagnostic instruments. The five-year agreement targets revenues of Rs. 70 crore by 2031.
Q1 FY27 saw 22% YoY revenue growth driven by service expansion. Successful migration to NSE main board and planned 100% acquisition of Saarathi Healthcare highlight strategic scale-up in Patient Support Programs (PSP).
QMS Medical Allied Services Ltd achieved a "Gold" certification in a cybersecurity assessment by CyberVadis. The company scored 918/1000, valid until August 2027.
QMS delivered strong Q1FY27 performance with 22% YoY revenue growth. Strategy focuses on scaling Services (Patient Support Programs) and expanding proprietary Q-Devices portfolio.
QMS Medical Allied Services Ltd reported revenue from operations of ₹56.9 Cr (+22.4% YoY) and net profit of ₹4 Cr (+25.0% YoY) for Q1 FY27.
QMS Medical Allied Services Limited will hold a board meeting on 14-Aug-2026 to consider and approve its unaudited quarterly financial results for June 2026.
QMS Medical Allied Services Limited announced that its subsidiary, Saarathi Healthcare Private Limited, has received a SOC 2 Type II certificate for its information security controls.